Search
for
Sort by
Research 181–210 of 1000+
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- Worldwide Clinical and Real-World Exposure to Baricitinib
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Skin cancer risk in alopecia areata: a systematic review and meta-analysis
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Characteristics and predictive values of super-responders in alopecia areata under tofacitinib treatment: A single-center retrospective study
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Clinical and Dermoscopic Evaluation of the Safety and Efficacy of Oral baricitinib (JAK Inhibitor) in Treatment of Localized Vitiligo Either Alone or with Topical Tacrolimus
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Current and future pharmacotherapy for alopecia areata
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Pharmacological Treatment of Alopecia
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- A transcriptomic map of murine and human alopecia areata
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- Free Papers Medical and Surgical: Hair and Nails
- P123 : Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and metaanalysis
- Supplementary Material for: Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024